Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
79.23
+14.03 (21.52%)
At close: Mar 9, 2026, 4:00 PM EDT
80.15
+0.92 (1.16%)
Pre-market: Mar 10, 2026, 4:03 AM EDT
Dianthus Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 51.09 | 22.79 | 132.33 | 15.37 | 7.64 |
| Short-Term Investments | 353.21 | 252.45 | 41.39 | 60.13 | - |
| Cash & Short-Term Investments | 404.3 | 275.24 | 173.72 | 75.49 | 7.64 |
| Cash Growth | 46.89% | 58.44% | 130.12% | 888.35% | - |
| Receivables | 0.05 | 0.81 | 0.48 | 5.64 | 1.48 |
| Inventory | 3.03 | 3.04 | 2.16 | 0.82 | 0.24 |
| Prepaid Expenses | 1.97 | 1.47 | 1.1 | 0.09 | 0.02 |
| Other Current Assets | 0.09 | 0.36 | - | - | 0.01 |
| Total Current Assets | 409.44 | 280.9 | 177.45 | 82.03 | 9.39 |
| Property, Plant & Equipment | 1.63 | 1.75 | 0.8 | 0.96 | 0.03 |
| Long-Term Investments | 110.14 | 81.73 | - | - | - |
| Other Long-Term Assets | 9.72 | 9.63 | 1.15 | 0.12 | 0.03 |
| Accounts Payable | 9.73 | 4.58 | 2.61 | 1.17 | 1.36 |
| Accrued Expenses | 19.45 | 13.07 | 6.5 | 6.61 | 3.99 |
| Current Portion of Leases | 0.37 | 0.32 | 0.42 | 0.35 | - |
| Current Unearned Revenue | 1.19 | 0.48 | 0.1 | 0.1 | - |
| Total Current Liabilities | 30.73 | 18.45 | 9.63 | 8.23 | 5.35 |
| Long-Term Leases | 1.02 | 1.17 | 0.17 | 0.44 | - |
| Long-Term Unearned Revenue | 5.77 | 1.91 | 0.74 | 0.79 | - |
| Common Stock | 0.04 | 0.03 | 0.02 | - | - |
| Additional Paid-In Capital | 829.6 | 526.73 | 258.23 | 1.66 | 0.14 |
| Retained Earnings | -336.73 | -174.39 | -89.42 | -45.87 | -17.39 |
| Comprehensive Income & Other | 0.49 | 0.11 | 0.05 | -0.16 | - |
| Total Common Equity | 493.4 | 352.48 | 168.87 | -44.37 | -17.25 |
| Total Liabilities & Equity | 530.92 | 374.01 | 179.41 | 83.11 | 9.45 |
| Total Debt | 1.39 | 1.49 | 0.59 | 0.79 | - |
| Net Cash (Debt) | 513.04 | 355.48 | 173.13 | 74.7 | 7.64 |
| Net Cash Growth | 44.32% | 105.32% | 131.76% | 878.03% | - |
| Net Cash Per Share | 13.29 | 10.67 | 33.60 | 85.45 | 1.91 |
| Filing Date Shares Outstanding | 44.47 | 32.13 | 29.35 | 4.01 | 4.01 |
| Total Common Shares Outstanding | 43.22 | 31.12 | 14.82 | 0.88 | 4.01 |
| Working Capital | 378.71 | 262.45 | 167.82 | 73.81 | 4.04 |
| Book Value Per Share | 11.42 | 11.33 | 11.40 | -50.69 | -4.31 |
| Tangible Book Value | 493.4 | 352.48 | 168.87 | -44.37 | -17.25 |
| Tangible Book Value Per Share | 11.42 | 11.33 | 11.40 | -50.69 | -4.31 |
| Machinery | 0.6 | 0.39 | 0.28 | 0.17 | - |
| Construction In Progress | - | - | - | - | 0.03 |
Source: S&P Capital IQ. Standard template.
Financial Sources.